Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novan Inc (NOVN)

Novan Inc (NOVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,636
  • Shares Outstanding, K 28,015
  • Annual Sales, $ 23,680 K
  • Annual Income, $ -31,310 K
  • 60-Month Beta -0.06
  • Price/Sales 0.15
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NOVN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.50
  • Most Recent Earnings $-0.54 on 05/15/23
  • Next Earnings Date 08/10/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +79.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0820 +14.76%
on 07/25/23
0.6252 -84.95%
on 07/12/23
-0.3259 (-77.60%)
since 06/23/23
3-Month
0.0820 +14.76%
on 07/25/23
1.3786 -93.17%
on 05/31/23
-1.1859 (-92.65%)
since 04/25/23
52-Week
0.0820 +14.76%
on 07/25/23
3.3300 -97.17%
on 08/12/22
-2.6959 (-96.63%)
since 07/25/22

Most Recent Stories

More News
Novan: Q1 Earnings Snapshot

Novan: Q1 Earnings Snapshot

NOVN : 0.0941 (-24.84%)
Ligand Reports First Quarter 2023 Financial Results

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2023, and provided an operating forecast and business updates. Ligand management...

LGND : 102.67 (+1.20%)
TVTX : 9.76 (+1.14%)
VKTX : 51.98 (+0.52%)
NOVN : 0.0941 (-24.84%)
NVS : 107.79 (-0.86%)
ANEB : 2.46 (+2.50%)
Novartis: Q1 Earnings Snapshot

Novartis: Q1 Earnings Snapshot

NOVN : 0.0941 (-24.84%)
NVS : 107.79 (-0.86%)
Novartis: Q4 Earnings Snapshot

Novartis: Q4 Earnings Snapshot

NOVN : 0.0941 (-24.84%)
NVS : 107.79 (-0.86%)
Ligand’s Partner Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Novan, Inc. (Nasdaq: NOVN) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking...

LGND : 102.67 (+1.20%)
NOVN : 0.0941 (-24.84%)
ViaSat, Nvidia rise; Cal-Maine Foods falls

Stocks that traded heavily or had substantial price changes Thursday: ViaSat, Nvidia rise; Cal-Maine Foods falls

NOVN : 0.0941 (-24.84%)
NVS : 107.79 (-0.86%)
XOM : 113.46 (-1.57%)
GS : 493.22 (+1.27%)
CALM : 64.91 (+0.65%)
DVN : 46.07 (-1.56%)
VSAT : 16.44 (+8.80%)
Novan: Q3 Earnings Snapshot

Novan: Q3 Earnings Snapshot

NOVN : 0.0941 (-24.84%)
Novartis: Q3 Earnings Snapshot

Novartis: Q3 Earnings Snapshot

NOVN : 0.0941 (-24.84%)
NVS : 107.79 (-0.86%)
Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update

– Total revenue of $6.2 million for the second quarter 2022 – – Activities on track for submission of berdazimer gel, 10.3% (SB206) New Drug...

NOVN : 0.0941 (-24.84%)
Novan to Report Second Quarter 2022 Financial Results on August 11, 2022

DURHAM, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its second...

NOVN : 0.0941 (-24.84%)

Business Summary

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through...

See More

Key Turning Points

3rd Resistance Point 0.1861
2nd Resistance Point 0.1628
1st Resistance Point 0.1285
Last Price 0.0941
1st Support Level 0.0709
2nd Support Level 0.0476
3rd Support Level 0.0133

See More

52-Week High 3.3300
Fibonacci 61.8% 2.0893
Fibonacci 50% 1.7060
Fibonacci 38.2% 1.3227
Last Price 0.0941
52-Week Low 0.0820

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar